vialaudit

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

Ion Peptide logo
VENDOR AUDIT·PUBLIC DATA·UPDATED 2026-10-12

Ion Peptide

US domestic10 peptides indexedpublic-data audit

US research-peptide vendor whose 106 Kovera Labs reports (median 99.93% purity, zero failures) remain its strongest signal - but those records live on the lab's side, because as of 12 October 2026 Ion's own site returns a site-wide Cloudflare block to us and retail prices are account-gated. Coded ION-X SKU naming on a subset of products carries a regulatory-exposure deduction.

81
OF 100
COMPOSITE — MID-TIER · STABLE
weighted across 4 facets

Score breakdown

40%
Purity
85/100
Composite of HPLC/MS chromatograms reviewed across mirrored COAs and any first-hand tests. Higher means cleaner peaks and fewer truncated-peptide artefacts.
25%
Pricing
75/100
Price per milligram against the median for the same compound and vial size across the vendors we track, at the sale price on the day we read the shop.
20%
Shipping & receipt
90/100
Stated processing and transit times, shipping policy, and the broader user-reported record. No first-hand order unless the page says so.
15%
Customer service
85/100
Published contact channels, refund and returns terms, operator transparency, and the user-reported record. No support test of ours unless the page says so.
Ion Peptide audit score 81 of 100: purity 85, pricing 75, shipping 90, customer service 85; 106 Kovera Labs reports with zero failures, median purity 99.93%, Trustpilot 4.7 from 435 reviews
Ion Peptide composite score and facets, from a public-data audit read 12 October 2026.

Strengths & weaknesses

+ STRENGTHS
  • 106 published Kovera Labs COAs (March - May 2026), the most of any single vendor in the audited cohort
  • Median purity 99.93% across all Kovera records; zero failed purity checks and zero identity-mismatch flags in the period
  • Same-day shipping with clear cutoffs (6pm EST weekdays, 3pm Saturday), FedEx 2-Day Express or UPS Ground
  • COA records resolve to the testing labs' own systems (Kovera Labs for the 106 records in our mirror) rather than to Ion Peptide's server, so the core evidence does not depend on the vendor's site staying reachable
  • About / team / mission pages with operator context as captured in May 2026 (we could not re-read them on 12 October 2026; see the access note)
  • Live chat staffed 9am - 1am EST daily when we captured it in May 2026; the homepage now advertises 24/7 support (vendor claim, not tested by us)
  • Standard 21 CFR 809.10(c) Research Use Only disclaimer in footer
  • Catalog spans 100+ SKUs: healing peptides (BPC-157, TB-500, GHK-Cu, KPV), longevity (NAD+, Glutathione, Thymosin alpha-1), CJC-1295/Ipamorelin, AOD-9604, Tesamorelin, Sermorelin, PT-141, and the coded ION-X line
  • Affiliate program advertised as "Research Partners" - they accept publisher arrangements
− WEAKNESSES
  • Coded ION-X SKUs (ION-1S, ION-2T, ION-3R) and symbol-prefix names (§-31, KSPTN) on a subset of products. This is the obfuscation pattern we documented in our [code-name-catalogs FDA-evasion article](/articles/code-name-catalogs-fda-evasion). Buyers should expect to email support or check COAs to confirm what's actually inside an ION-3R vial. Cuts both ways - the obfuscation hedges against FDA enforcement letters but reduces per-SKU clarity at the cart
  • Scored on public records only - vialaudit has placed no test order
  • Prices sit behind an account. The May 2026 capture showed a wholesale sign-in (business type Researcher / Clinic / University / Distributor) gating some tiers, and a 24 September 2026 affiliate roundup says an account is needed to see prices at all. We could not confirm current retail prices from the public site
  • Newer brand by domain age (domain registered 11 August 2025) - the Kovera records in our mirror only span 22 March to 28 May 2026 (mirror built 1-2 August), so long-term batch consistency is not yet measurable
  • The ION-X coded products are not in our Kovera identity-mismatch dataset because Kovera cannot match a coded SKU to a reference compound. The 99.93% median purity figure applies to identifiable compounds; coded-SKU verification is more limited
  • Access check, 12 October 2026: every page we requested on ionpeptide.com, including the homepage and robots.txt, returned a Cloudflare 'Sorry, you have been blocked' page (HTTP 403) on three separate capture routes. A third-party page reader could still retrieve the homepage and /lab-results/, and Trustpilot shows customer reviews through 8 October, so we read this as an access filter (country, network or bot rules) and not a shutdown. We cannot say which rule applies, and we could not re-capture Ion's own COA library ourselves
  • Where the peptides are made is not verified: the homepage says many products come from 'U.S.-based or GMP-compliant' laboratories, which is not a claim of US manufacture for every SKU

What it sells

10 PEPTIDES WE COVER

Shipping & payment

FROM PUBLISHED POLICY AND USER REPORTS
DOMESTIC SHIPPING · STATED
3.0d
PAYMENT
cardcrypto
LAST REVIEWED
2026-10-12

Public reviews

TRUSTPILOT · READ 2026-10-19
TRUSTSCORE
4.7 / 5
REVIEWS
435
FIVE-STAR · ONE-STAR
90% · 5%

Recurring complaints in the one- and two-star reviews: card charges reviewers did not authorise, or double charges, after ordering; late or missing deliveries, including paid express orders; vials cloudy or gelled after reconstitution, no replacement; reviewers saying negative reviews were removed. All 435 reviews were posted in the past 12 months, including 11 five-star reviews on 31 August 2026. Trustpilot shows only the first ten pages without an account, so we could not read the oldest review. This is a second-hand signal. Nearly every peptide shop on Trustpilot scores between 4.3 and 5.0, so we weigh the spread, the dates and the complaints rather than the headline score, and never above a lab result. Read the profile.

Audit notes

FROM THE BENCH
Screenshot of Ion Peptide's wholesale research supply portal showing the Ion Peptide hexagonal logo, sign-in/register form, 'High-Purity Research Compounds' heading, and three value props: Institutional & Bulk Pricing, USA Verified COAs, Reliable Operations & Support.
Ion Peptide wholesale portal as captured during this audit. Public store sits behind a registration wall for some catalog tiers. Source: ionpeptide.com via Wayback, May 2026.

What Ion Peptide actually is

Ion Peptide is a US-based research-peptide vendor operating from a WordPress + WooCommerce storefront with a parallel wholesale-portal flow for distributors and clinics. The site presents as a relatively new entry to the audited cohort - the Wayback Machine first-archive date is mid-2025 and the Kovera testing pattern starts March 2026.

The catalog is structured around two parallel naming conventions. Most healing, longevity, and growth-factor peptides ship under their standard chemical names (BPC-157, GHK-Cu, CJC-1295/Ipamorelin, Tesamorelin, Sermorelin, PT-141). A subset of products ship under the coded ION-X naming convention (ION-1S, ION-2T, ION-3R) plus symbol-prefixed names (§-31, KSPTN). This is the obfuscation pattern we documented in our code-name catalogs article - a hedge against FDA enforcement letters that ask "are you selling compound X" rather than "what is in your ION-X SKU."

The COA practice is where Ion Peptide stands out.

Why Ion Peptide leads on COA volume

An earlier version of this page said 120 reports. We could not reconcile that with any client-name or email alias in our mirror, so we now count records whose client name is exactly "Ion Peptide".

Across the 106 records in our Kovera Labs mirror whose client name reads "Ion Peptide" (analysis dates 22 March to 28 May 2026; mirror built 1-2 August 2026), Ion Peptide carries:

SignalValue
Total Kovera COAs published106
Median measured purity99.93% (99 records with a purity value)
Records below 95% purity0
Records with identity-mismatch flag0
Records with explicit purity failure0

That's the cleanest two-month batch in our entire Kovera-tested vendor pool. For context, the next closest heavy publisher (Glacier Aminos at 77 records) carries 3 identity-mismatch flags, and the third (Instant Peptides at 72 records) carries 5 purity failures plus 3 identity-mismatch flags. Ion Peptide simply has no flagged records in the period.

The records cover the meaningful diversity of their catalog: BPC-157, BPC-157/TB-500 blends, CJC-1295/Ipamorelin, GHK-Cu/KPV blends, PT-141, Tesamorelin, Sermorelin, AOD-9604, Glutathione, Thymosin alpha-1, plus the coded ION-X line and the symbol-prefixed §-31 and KSPTN entries.

We covered the broader Kovera corpus methodology in our 1,816-COA analysis - same independent lab, same per-record verifier URL pattern, same publication discipline (failures appear alongside passes in Kovera's public listing, which is the structural property that makes the corpus a credible signal in the first place). Every one of the 106 certificates, with lot, purity and a verify link, is on our Ion Peptide Kovera page.

What the records cover, and what they do not

These 106 records live on Kovera Labs' side, not on Ion Peptide's website, which is why the finding survives the access block described above. They also stop at 28 May 2026 in our mirror (built 1-2 August), so they say nothing about batches shipped since. A disclosed-affiliate review on r/peptidebenchmark (28 July 2026) describes Ion Peptide's library as drawing on a second lab, reporting 114 Freedom Diagnostics reports plus 37 Kovera reports. That differs from our count of 106 Kovera records by client name. We have not reconciled the two or verified any Freedom Diagnostics report, so we do not rely on it.

Independent tests: Finnrick

Finnrick, an independent testing publication, lists Ion Peptide at 82% (rank 38 of 457 vendors) under its purity-focus standard (purity of 99.5 percent or higher, dose within 35 percent of the label). Four of four classifiable tests passed: one on 10 February 2026, one on 6 June and two on 22 July. All four are retatrutide; Finnrick shows no tests for the nine other compounds it lists for Ion Peptide. The rating moved from 78% to 81% to 82% across those dates. Per-test purity and dose figures sit behind Finnrick's membership, so we read the headline only. Four tests on one compound is thin evidence, but it is the only independent re-test of Ion Peptide product we found, and it does not contradict the lab certificates.

The coded-SKU caveat

The audit credits Ion Peptide heavily for the COA pattern, but the coded ION-X line deserves explicit framing because it cuts in two directions.

The argument for: in a regulatory environment where FDA enforcement letters often cite "Vendor X is selling compound Y," a vendor using ION-3R as a SKU has a defensible "we sold ION-3R, you'll have to subpoena us to learn what's in it" posture. That's the same defensive posture we documented across multiple alias-cluster vendors in our 32-vendor alias scan.

The argument against: a buyer comparing Ion Peptide to a vendor using clear chemical names cannot do a like-for-like comparison at the cart. The Kovera COA for an ION-3R vial will identify the compound (the lab can run mass spec independent of what the vendor calls it), but the buyer has to read that COA carefully before they know what they are actually buying. For a research-protocol audience that knows the field, this may be acceptable. For a less-expert buyer, it's a friction.

The composite carries the methodology's regulatory-exposure deduction for code-name SKUs of this kind. The COA disclosure pattern is why that deduction does not go further, but it remains a real consideration buyers should hold.

Where Ion Peptide is based and who runs it

Ion Peptide presents as a US-based research-peptide supplier. The same-day shipping cutoffs are quoted in Eastern time (6pm weekdays, 3pm Saturday), which points to a US East Coast fulfillment footprint, and carriers are domestic (FedEx 2-Day Express, UPS Ground). The site publishes about, team, and mission pages - more operator context than most vendors in this cohort - but it does not name a company officer publicly, and we have not yet matched a named owner against state business-registration records. That cross-check is part of the full-audit upgrade below.

Pricing is gated: our May 2026 capture showed some catalog tiers displaying prices only after wholesale registration (business type: Researcher / Clinic / University / Distributor), and a 24 September 2026 affiliate roundup says an account is needed to see prices at all. We could not read current retail prices because the site blocked our 12 October 2026 captures, so the pricing subscore rests on the May capture. Payment was card or crypto as of that capture. Because catalog prices move, confirm the current price - and the batch COA - at checkout rather than trusting a third-party quote.

Shipping, support, payments

Shipping: Same-day fulfillment on orders placed before 6pm EST Monday-Friday or 3pm Saturday. Carriers are FedEx 2-Day Express or UPS Ground. The same-day cutoff with named carriers is a transparency signal most vendors in the niche don't publish explicitly.

Support: Live chat was staffed 9am-1am EST daily when we captured the site in May 2026 (16-hour coverage, no weekends-off gap); the homepage now advertises 24/7 support, which we have not tested. Email channel via the contact page.

Payments: Card via the WooCommerce default, plus crypto handling typical for the category. We could not confirm wire / ACH availability from the public site.

Wholesale portal: Some catalog tiers require account registration. The registration flow asks for business type (Researcher / Clinic / University / Distributor / Other) and date-of-birth verification. This is mainstream for the category.

What's missing from public records

This audit is public-data tier. Public records leave these open:

  • Whether a retail vial matches its certificate. vialaudit has placed no order with Ion Peptide and sent no vial to a lab
  • Cross-check of an ION-X coded SKU against the COA-stated compound, to confirm what the coded SKUs actually contain
  • Per-batch consistency check across 6-12 months of testing, not just the two-month March-May 2026 Kovera window
  • A re-capture of Ion Peptide's own lab-results library from a US network location, to confirm it is still itemised by batch (our 12 October 2026 captures were blocked)
  • Reconciliation of Kovera and Freedom Diagnostics record counts, and a check of Freedom Diagnostics reports against that lab's own verifier
  • Verification of state-by-state shipping policy and any blocked-state restrictions
  • Confirmation of payment-method coverage beyond what the public catalog displays
  • The named operator behind the brand, cross-checked against state business-registration records

This profile reflects what is verifiable from public records as of the last-tested date, plus the 12 October 2026 access check and Finnrick read described above.

Editorial note - the COA-pattern leader, with a caveat

Ion Peptide holds the highest COA-volume rank in our audited cohort. 106 Kovera COAs at 99.93% median purity with zero flags is the cleanest two-month publishing record we have measured, and Finnrick's four retatrutide tests all passed. The audit still weights this heavily, but we trimmed the COA-quality subscore from 9.5 to 8.5 in October 2026: the Kovera window is short and ends in May, we could not re-read Ion Peptide's own library, and retail prices now appear to sit behind an account.

There are two caveats. The coded ION-X SKU pattern is not disqualifying - the COA disclosure compensates - but buyers should treat ION-3R or §-31 in the cart the same way they would treat any unfamiliar SKU: read the COA before buying. The access filter on the vendor's own site is the second: it may be a bot or country rule rather than a withdrawal of records, and a re-check from a US network location is on our list.

See our methodology for the rubric weights that produce this score and the conflict-of-interest constraints that govern this desk.

Sources

11 REFERENCES

Other vendors we've audited

VIEW ALL →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH